Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AB1 | P08238 | 4/20 | 0.82 |
| ▸ | CYP19A1 | P11511 | 12/20 | 0.74 |
| ▸ | NPC1 | O15118 | 2/20 | 0.60 |
| ▸ | RAB9A | P51151 | 2/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3766130 | 0.88 | HSP90AB1 (0.66) | HSP90AB1CYP19A1NPC1RAB9AHRH4 | |
| SCHEMBL22266581 | 0.87 | HSP90AB1 (0.65) | HSP90AB1CYP19A1NPC1RAB9A | |
| SCHEMBL1715655 | 0.87 | CYP19A1 (0.70) | HSP90AB1CYP19A1NPC1RAB9AHRH4 | |
| SCHEMBL84637 | 0.85 | CYP19A1 (1.00) | HSP90AB1CYP19A1 | |
| SCHEMBL12673479 | 0.84 | CYP19A1 (0.76) | HSP90AB1CYP19A1NPC1RAB9A | |
| SCHEMBL6429043 | 0.83 | CYP19A1 (0.65) | HSP90AB1CYP19A1NPC1RAB9AHRH4 | |
| SCHEMBL3103838 | 0.82 | CYP19A1 (0.68) | HSP90AB1CYP19A1NPC1RAB9AHRH4 | |
| SCHEMBL12022159 | 0.82 | KCNMA1 (0.69) | HSP90AB1CYP19A1NPC1RAB9AHRH4 | |
| SCHEMBL28920959 | 0.81 | HSP90AB1 (0.64) | HSP90AB1CYP19A1 | |
| SCHEMBL2494737 | 0.81 | NOTUM (0.73) | HSP90AB1CYP19A1NPC1RAB9AL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110172417-A1 | Heterogeneous Copper Nanocatalyst and Manufacturing Methods Thereof | POSTECH ACADEMY-INDUSTRY FOUNDATION (KR) | 2011-07-14 | — | — | US | claimed |
| US-9375705-B2 | Heterogeneous copper nanocatalyst and manufacturing methods thereof | POSTECH ACADEMY-INDUSTRY FOUNDATION (KR) | 2016-06-28 | — | — | US | disclosed |
| US-8877676-B2 | Heterogeneous copper nanocatalyst and manufacturing methods thereof | POSTECH ACADEMY-INDUSTRY FOUNDATION (KR) | 2014-11-04 | — | — | US | disclosed |
| US-8877676-B2 | Heterogeneous copper nanocatalyst and manufacturing methods thereof | POSTECH ACADEMY-INDUSTRY FOUNDATION (KR) | 2014-11-04 | — | — | US | disclosed |
| US-8877676-B2 | Heterogeneous copper nanocatalyst and manufacturing methods thereof | POSTECH ACADEMY-INDUSTRY FOUNDATION (KR) | 2014-11-04 | — | — | US | disclosed |
| US-20140302984-A1 | HETEROGENEOUS COPPER NANOCATALYST AND MANUFACTURING METHODS THEREOF | POSTECH ACADEMY-INDUSTRY FOUNDATION (KR) | 2014-10-09 | — | — | US | disclosed |
| US-20110172417-A1 | Heterogeneous Copper Nanocatalyst and Manufacturing Methods Thereof | POSTECH ACADEMY-INDUSTRY FOUNDATION (KR) | 2011-07-14 | — | — | US | disclosed |
| US-20110172417-A1 | Heterogeneous Copper Nanocatalyst and Manufacturing Methods Thereof | POSTECH ACADEMY-INDUSTRY FOUNDATION (KR) | 2011-07-14 | — | — | US | disclosed |
| US-20110172417-A1 | Heterogeneous Copper Nanocatalyst and Manufacturing Methods Thereof | POSTECH ACADEMY-INDUSTRY FOUNDATION (KR) | 2011-07-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110172417-A1 | Heterogeneous Copper Nanocatalyst and Manufacturing Methods Thereof | AOC3, AOC2, USP13 | HSP90AB1 3863/4885CYP19A1 2195/4885NPC1 3004/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.